Skylands Capital, LLC Bio Rad Laboratories, Inc. Transaction History
Skylands Capital, LLC
- $684 Million
- Q3 2024
A detailed history of Skylands Capital, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Skylands Capital, LLC holds 1,500 shares of BIO stock, worth $497,085. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,500
Previous 1,400
7.14%
Holding current value
$497,085
Previous $382,000
31.15%
% of portfolio
0.07%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding BIO
# of Institutions
456Shares Held
18.2MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.91MShares$632 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$514 Million0.01% of portfolio
-
Van Eck Associates Corp1.3MShares$432 Million0.55% of portfolio
-
Veritas Asset Management LLP1.09MShares$360 Million3.03% of portfolio
-
First Eagle Investment Management, LLC713KShares$236 Million0.5% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.16B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...